Clinical Trial Update: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Yangxinshi Pills with Trimetazidine in patients after percutaneous coronary intervention has completed, evaluating exercise tol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Trimetazidine (trimetazidine)
• Yangxinshi Pills

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED